ArticleEuropean journal of pediatrics2026
Cardiorespiratory coupling during high-frequency oscillatory ventilation with volume guarantee in extremely preterm infants.
Article in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aims to evaluate associations between PCA-derived cardiovascular components and respiratory burden during high-frequency oscillatory ventilation with volume guarantee (HFOV-VG). This retrospective cohort study included infants born before 30 weeks of gestation who received HFOV-VG and underwent targeted neonatal echocardiography during respiratory support. Echocardiography assessed ventricular systolic function, cardiac output, myocardial deformation, and pulmonary vascular loading. Principal component analysis (PCA) derived integrated cardiovascular components. Multivariate regression models evaluated associations with respiratory support, haemodynamic support, and clinical outcomes, including mortality, moderate-to-severe bronchopulmonary dysplasia (BPD), and the composite outcome of death or moderate-to-severe BPD. Sixty-two infants were included (gestational age 26.0 [25.0-27.0] weeks; birth weight 860 [700-1000] g). Median FiO₂ during HFOV-VG was 0.35 (0.31-0.52). Right ventricular strain demonstrated the strongest association with FiO₂ (rho = 0.53, q < 0.001). The first principal component (PC1), representing a cardiopulmonary loading component characterised by less favourable ventricular performance, reduced cardiac output, altered myocardial deformation, and increased septal loading, explained 65.9% of echocardiographic variance. Each one standard deviation increase in PC1 was associated with a 0.60 standard deviation increase in FiO₂ (95% CI 0.38-0.82; p < 0.001). Higher PC1 was independently associated with mortality (OR 3.01, 95% CI 1.44-6.29; p = 0.004), higher peak vasoactive-inotropic score, longer inotropic support, increased odds of inotrope use, and lower odds of haemodynamically significant patent ductus arteriosus (all p < 0.05).
conclusionIn preterm infants receiving HFOV-VG, the first cardiovascular principal component was independently associated with oxygenation burden, haemodynamic support requirements, and mortality. PCA-derived cardiovascular assessment may complement conventional respiratory assessment during HFOV-VG. WHAT IS KNOWN: • Oxygenation during high-frequency oscillatory ventilation is influenced by both respiratory and cardiovascular factors. • Targeted neonatal echocardioghraphy can assess multiple aspects of cardiovascular function, but most studies have evaluated individual haemodynamic variables rather than integrated cardiovascular profiles. WHAT IS NEW: • Exploratory principal component analysis identified a cardiovascular component independently associated with oxygen requirements during HFOV-VG. • The first principal component was independently associated with oxygenation burden, haemodynamic support requirements, and mortality, supporting an integrated cardiorespiratory approach to physiological assessment during HFOV-VG.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.